Working… Menu

Study of Evobrutinib in Participants With RMS (evolutionRMS 1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04338022
Recruitment Status : Recruiting
First Posted : April 8, 2020
Last Update Posted : July 19, 2021
EMD Serono Research & Development Institute, Inc.
Information provided by (Responsible Party):
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 18, 2023
Estimated Study Completion Date : July 10, 2026